"New HIV drug appears to be very potent"
Globe and Mail
15 Aug 2022
Category: Pharmaceutical
Rating:
(4½ stars)
what they said (Hover the mouse cursor over underlined words for more info)
TORONTO - Patients taking a brand new type of HIV drug have shown a quick reduction in the number of viruses circulating in their bloodstream, according to early data from a clinical trial that is to be announced at the International AIDS Conference in Toronto later this week. The drug belongs to a long-awaited new class of HIV medications known as integrase inhibitors. They work to block the enzyme the virus uses to integrate its genetic material into the DNA of a host's cell and make copies of itself....
The original article can be found at: http://www.theglobeandmail.com/servlet/story/RTGAM.20060813.aids-drug14/BNStory/Front/
The original article can found in the Media Doctor archives.
Criteria |
Rating |
Availability of Treatment |
Satisfactory (?) |
Costs of Treatment |
Not Applicable |
Disease Mongering |
Satisfactory (?) |
Evidence |
Satisfactory (?) |
Harms of Treatment |
Satisfactory (?) |
Novelty of Treatment |
Satisfactory (?) |
Quantification of Benefits of Treatment |
Satisfactory (?) |
Quantification of Harms of Treatment |
Not Satisfactory (?) |
Relies on Press Release |
Not Applicable |
Sources of Information |
Satisfactory (?) |
Treatment Options |
Satisfactory (?) |
what we said (Hover the mouse cursor over underlined words for more info)
This journalist provided an unusually descriptive account of the details of the clinical trial including independent commentary on the significance of the research. It was particularly notable that the inclusion criteria were given for study participants. Some mention of the expected timeline for the drug to enter the market would have been useful to the reader as would have a better quantification of the potential harms involved.
public forum
There are currently no comments on this article.
|